Becaplermin

Discover Becaplermin, a recombinant human platelet-derived growth factor (rhPDGF-BB) used to accelerate healing in chronic diabetic foot ulcers. Learn abou

Becaplermin for diabetic foot ulcers Becaplermin wound healing rhPDGF-BB treatment Diabetic foot ulcer medication Chronic wound therapy Becaplermin gel application Platelet-derived growth factor Becaplermin side effects Topical growth factor
🏷 ATC Code: D11AX16 📂 Other dermatological preparations 🕐 Updated: Mar 13, 2026 ✓ Medical Reference

Looking to order Becaplermin?

Browse our catalog for available pharmaceutical products and competitive pricing.

What is Becaplermin?

Becaplermin is a fascinating and effective topical medication primarily used to promote the healing of chronic wounds. It is a recombinant human platelet-derived growth factor-BB (rhPDGF-BB treatment), a synthetically produced version of a natural protein found in the human body. This protein plays a crucial role in various physiological processes, most notably in cell growth, proliferation, and differentiation, which are all vital for tissue repair. Essentially, Becaplermin provides a concentrated dose of this healing signal directly to the wound site.

Its unique mechanism of action makes it particularly valuable for wounds that struggle to heal on their own, especially those associated with underlying conditions like diabetes. As a wound healing medication, it is formulated as a gel for direct application, ensuring that its therapeutic effects are delivered precisely where they are needed most.

How Does it Work?

The efficacy of Becaplermin stems from its ability to mimic the natural actions of platelet-derived growth factor (PDGF) in the body. When an injury occurs, platelets release PDGF, which then acts as a potent signaling molecule. Becaplermin, being rhPDGF-BB, binds to specific receptors on various cell types, including fibroblasts, smooth muscle cells, and macrophages, which are all critical players in the wound healing cascade.

Upon binding, Becaplermin initiates a cascade of events that collectively accelerate the healing process. These include:

  • Chemotaxis: It attracts cells essential for healing, such as fibroblasts and macrophages, to the wound site.
  • Cell Proliferation: It stimulates the growth and multiplication of these cells, particularly fibroblasts, which are responsible for producing collagen and other extracellular matrix components.
  • Collagen Synthesis: By promoting fibroblast activity, Becaplermin enhances the production of collagen, the primary structural protein of connective tissue, which is crucial for building new tissue.
  • Granulation Tissue Formation: The combined effect of cell proliferation and collagen synthesis leads to the formation of healthy granulation tissue, a key step in closing chronic wounds.

By augmenting these natural processes, Becaplermin helps to jumpstart and sustain healing in wounds that would otherwise remain stagnant.

Medical Uses

The primary medical indication for Becaplermin is as an adjunct to good ulcer care for the treatment of full-thickness, non-healing, lower extremity diabetic neuropathic ulcers that extend into the subcutaneous tissue or beyond, and which have an adequate blood supply. This means it is specifically designed for Becaplermin for diabetic foot ulcers – a significant and challenging complication of diabetes.

It is important to note that Becaplermin is not intended for all types of wounds. Its use is typically reserved for chronic wounds that have not responded to conventional treatments and where the underlying cause of poor healing is related to a deficiency in growth factors. It should always be used under the guidance of a healthcare professional and as part of a comprehensive wound management plan, which includes debridement, infection control, and pressure relief.

Dosage

Becaplermin is available as a topical gel and is typically applied once daily. The exact dosage and duration of treatment will be determined by a healthcare provider based on the size and nature of the wound. Generally, a thin layer of the gel is applied directly to the entire surface of the clean, debrided wound. After application, the wound is usually covered with a non-occlusive dressing to protect it and allow for proper air circulation.

Before each application, it is crucial that the wound is thoroughly cleaned and debrided to remove any necrotic tissue, which can impede the gel's effectiveness. Treatment with Becaplermin usually continues until the ulcer is completely healed or for a maximum of 20 weeks, whichever comes first. Adherence to the prescribed regimen is vital for achieving optimal healing outcomes.

Side Effects

While Becaplermin is generally well-tolerated, like all medications, it can have side effects. The most common side effects are usually local reactions at the application site, such as mild skin irritation, redness (erythema), or a burning sensation. These are often transient and resolve on their own.

However, a more serious concern associated with Becaplermin is a potential increased risk of cancer recurrence in patients with a history of malignancy. For this reason, it is contraindicated in patients with known malignancy at the site of application. Patients with a history of cancer should discuss this risk thoroughly with their doctor before using Becaplermin. Your doctor will weigh the benefits of enhanced wound healing against any potential risks.

Drug Interactions

Due to its topical application and limited systemic absorption, Becaplermin is not known to have significant systemic drug interactions with orally administered medications. This means it is unlikely to interfere with other medications you might be taking for unrelated conditions.

However, caution should be exercised when using other topical agents concurrently at the same wound site. Applying multiple topical medications simultaneously could potentially alter the absorption or effectiveness of Becaplermin, or vice versa. It is always best to inform your healthcare provider about all medications, supplements, and herbal remedies you are using, including any other topical treatments, to ensure there are no potential interactions that could compromise your chronic wound therapy.

FAQ

Is Becaplermin safe for long-term use?

Becaplermin is typically used for a limited duration, often up to 20 weeks, or until complete wound healing. Long-term safety beyond this period has not been extensively studied, and its use should always be guided by a healthcare professional, especially given the warning regarding malignancy history.

How quickly can I expect to see results with Becaplermin?

The time to see results can vary depending on the individual patient, the size and severity of the ulcer, and adherence to the overall wound care plan. While some improvement may be observed within weeks, complete healing of chronic ulcers often takes several months.

Can Becaplermin be used for wounds other than diabetic foot ulcers?

Becaplermin is specifically approved for full-thickness diabetic neuropathic ulcers. Its use for other types of wounds is off-label and should only be considered under strict medical supervision and if the benefits are deemed to outweigh the risks.

How should Becaplermin gel be stored?

Becaplermin gel should be stored in a refrigerator at 2°C to 8°C (36°F to 46°F). It should not be frozen. Always check the product packaging for specific storage instructions.

Is Becaplermin available over-the-counter?

No, Becaplermin is a prescription-only medication and must be obtained with a valid prescription from a licensed healthcare provider.

Products containing Becaplermin are available through trusted online pharmacies. You can browse Becaplermin-based medications at ShipperVIP or Medicenter.

Summary

Becaplermin for diabetic foot ulcers represents a significant advancement in the management of chronic wounds. As a recombinant human platelet-derived growth factor (rhPDGF-BB), it actively stimulates the cellular processes necessary for wound repair, offering hope for patients suffering from persistent non-healing ulcers. While it is a powerful chronic wound therapy, its use requires careful consideration, particularly regarding potential risks like cancer recurrence in certain patient populations. Always consult with a healthcare professional to determine if Becaplermin is the appropriate treatment option for your specific wound care needs, ensuring it is integrated into a comprehensive and individualized healing strategy.